Senvest Management, LLC Uni Qure N.V. Transaction History

Senvest Management, LLC

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2020 Feb 12, 2021	SELL	$35.35 - $50.67 $11.4 Million - $16.3 Million	-322,344 Closed	0 $0
Q3 2020 Nov 13, 2020	BUY	$35.98 - $47.66 $8.15 Million - $10.8 Million	226,644 Added 236.83%	322,344 $11.9 Million
Q2 2020 Aug 13, 2020	BUY	$45.06 - $67.74 $4.31 Million - $6.48 Million	95,700 New	95,700 $4.31 Million
Q1 2020 May 14, 2020	SELL	$40.01 - $73.97 $8 Million - $14.8 Million	-199,884 Closed	0 $0
Q4 2019 Feb 13, 2020	BUY	$37.13 - $74.62 $2.74 Million - $5.51 Million	73,784 Added 58.51%	199,884 $14.3 Million
Q3 2019 Nov 13, 2019	BUY	$39.36 - $76.8 $3.72 Million - $7.26 Million	94,475 Added 298.74%	126,100 $4.96 Million
Q2 2019 Aug 13, 2019	SELL	$52.76 - $82.19 $1.21 Million - $1.89 Million	-23,000 Reduced 42.11%	31,625 $2.47 Million
Q1 2019 May 14, 2019	BUY	$27.39 - $68.41 $1.5 Million - $3.74 Million	54,625 New	54,625 $3.26 Million

142

35.3M

1.54M

389K

Ticker QURE
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 46,729,100
Market Cap $300M
Description
uniQure N.V., a gene therapy company, engages in the development of treatments for patients suffering from genetic and other devastating diseases. Its lead program is Etranacogene dezaparvovec (AMT-061), which is in Phase III HOPE-B pivotal trial for the treatment of hemophilia B. The company also engages in developing AMT-130, a gene therapy th...

Get notified when there are updates to the investment portfolio of Senvest Management, LLC, based on Form 13F filings with the SEC.

Stay updated on Senvest Management, LLC with notifications on news.